In overall, these results suggest that Ngfr signaling reduces amyloid and Tau pathology concomitant to enhancing adult hippocampal neurogenesis in APP/PS1dE9 mouse model of Alzheimer’s disease. The gene discussed is NGFR; the disease is early-onset autosomal dominant Alzheimer disease.